Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Midterm Efficacy of SubcutAneous Implantable CardioVErter-Defibrillator in ≤ 18 Year-Old CHILDREN (SAVE CHILDREN-II Registry).

Journal of arrhythmia·2026
Same author

Stepwise Progression and Successful Extraction of a Completely Transected EMBLEM S-ICD Model 3501 Lead.

Journal of arrhythmia·2026
Same author

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Circulation·2026
Same author

Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis.

JACC. Asia·2026
Same author

Novel Echocardiographic Index for Risk Stratification of Ventricular Arrhythmias and Mortality Based on Right Ventricular Function.

Journal of arrhythmia·2026
Same author

Silent cerebral microvascular disease and the longitudinal risk of cognitive decline in atrial fibrillation.

Scientific reports·2025

相关实验视频

Updated: Jan 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K

左心房尾关闭:目前的情况,未解决的问题,以及未来的前景.

Yusuke Kondo1, Satoko Ryuzaki2, Miyo Nakano3

  • 1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, 260-8670, 1-8-1 Inohana, Chuo-ku, Japan. simokita9933@msn.com.

Cardiovascular intervention and therapeutics
|December 11, 2025
PubMed
概括

左心房尾关闭 (LAAC) 为无法使用口服抗凝剂 (OAC) 的非膜心房动 (AF) 患者提供中风预防. 目前正在进行的研究重点是优化设备安全,减少与设备相关的血栓等并发症,并扩大LAAC的指示.

关键词:
心房动 (AF) 是一种心房动.左心房尾关闭 (LAAC) 的情况非膜性心房动 (NVAF) 是一种非膜性心房动.一次性中风,中风.

更多相关视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.2K

相关实验视频

Last Updated: Jan 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.2K

科学领域:

  • 心脏病学 心脏病学
  • 医疗器械 医疗器械
  • 预防中风 预防中风

背景情况:

  • 左心房附属体关闭 (LAAC) 是非膜心房动 (AF) 患者的关键中风预防疗法,口服抗凝剂 (OAC) 禁用.
  • 在日本,LAAC的采用正在增加,超过了10,000个程序.
  • 目前的适应症仅限于高危患者.

研究的目的:

  • 审查LAAC的当前状态,挑战和未来方向,重点关注WATCHMAN设备.
  • 讨论LAAC设备和成像技术的进展.
  • 探索未来扩大LAAC使用和改善患者治疗结果的优先事项.

主要方法:

  • 对评估LAAC设备 (WATCHMAN FLX,FLX Pro, Amulet) 的临床试验和注册表的审查.
  • 与口服抗凝药相比,安全性和疗效数据的分析.
  • 评估新兴技术,如心内心声谱 (ICE) 和脉冲场切除 (PFA).

主要成果:

  • 拉克证明了与OAC可比的中风预防效果,但出血风险较低.
  • WATCHMAN FLX/FLX Pro显示出更好的安全性和适应性.
  • 与设备相关的血栓 (DRT) 和周围设备泄漏 (PDL) 仍然是需要优化抗血栓治疗的重大问题.
  • 护身符提供了更好的密封性,但并发症率更高.
  • ICE 能够实现更少的侵入性手术和同期 AF 切除.

结论:

  • 对于选定的AF患者来说,LAAC是一种有效的中风预防策略.
  • 解决DRT和PDL对于长期成功至关重要.
  • 像ICE和PFA这样的技术进步正在提高程序效率,并使综合方法成为可能.
  • 未来的研究应该侧重于风险分层,个性化抗血栓治疗方案,以及扩大LAAC的适用范围.